JOURNAL OF CLINICAL SURGERY ›› 2024, Vol. 32 ›› Issue (7): 757-761.doi: 10.3969/j.issn.1005-6483.2024.07.023

Previous Articles     Next Articles

Correlation of serum miR-143-3p and ATG2B levels with clinicopathology and postoperative survival in patients with radical cystectomy

LU Huiqing,ZHAO Youwei,LIU Wei   

  1. Department of Thoracic Surgery,Shijiazhuang Third Hospital,Shijiazhuang,Hebei 050011,China
  • Received:2023-05-12 Online:2024-07-20 Published:2024-07-20

Abstract: Objective To investigate the expression of miR-143-3p and ATG2B in serum of patients with bladder cancer and their relationship with clinicopathology,prognosis and survival of patients.Methods Eighty-eight patients who underwent radical bladder cancer surgery in our hospital from January 2017 to January 2019 were regarded as the research group,and 80 volunteers who underwent physical examination in our hospital were included as the control group.Quantitative real-time PCR (qRT-PCR) method was performed to detect the levels of miR-143-3p and ATG2B;The predictive value of miR-143-3p and ATG2B for bladder cancer was evaluated by ROC curve.Draw survival curve using Kaplan Meier method;The prognostic factors of bladder cancer patients were analyzed by Cox regression.Results The expression level of miR-143-3p in the serum of bladder cancer patients was lower than that in the control group (0.68±0.12 vs. 0.87±0.26),and the expression level of ATG2B was higher (1.02±0.30 vs. 0.61±0.18) (P<0.05);the expression level of miR-143-3p in serum of postoperative patients was higher than that before operation (0.77±0.23 vs. 0.68±0.12),and the expression level of ATG2B was lower than that before operation (0.85±0.26 vs. 1.02±0.30) (P<0.05);The study group showed a negative correlation between miR-143-3p and ATG2B expression (r=-0.454,r=-0.407,P<0.01);The AUC of miR-143-3p in the diagnosis of bladder cancer was 0.846 (95%CI:0.783-0.897),the sensitivity and specificity were 79.55% and 78.75% respectively;The AUC of ATG2B in the diagnosis of bladder cancer was 0.883 (95%CI:0.824-0.927),the sensitivity and specificity were 78.41% and 81.25% respectively;The AUC for the diagnosis of bladder cancer was 0.939 (95%CI:0.891-0.970),the sensitivity and specificity were 87.50% and 88.75%,respectively.The 3-year survival rate of the miR-143-3p low expression group was 34.88% (15/43) lower than that of the high expression group 77.78% (35/45),and the 3-year survival rate of the ATG2B high expression group was 40.91% (18/44) lower than that of the low expression group 72.73% (32/44).The differences were statistically significant (Log rank χ2=18.055,8.658,P=0.000,0.003).Lymph node metastasis,distant metastasis,tumor pathological grade,TNM stage,miR-143-3p,ATG2B are all factors influencing the survival of bladder cancer patients.Conclusion The serum expression of miR-143-3p in patients with bladder cancer is low,and the expression of ATG2B is high,and the expressions of the two are closely related to the clinicopathological characteristics and prognosis of patients with bladder cancer.

Key words: bladder cancer, miR-143-3p, ATG2B, clinicopathological features, prognosis

[1] FENG Nan, LIN Hongqian, GUO Yijin, WANG Yajiao. Analysis of risk factors for prognosis in patients with esophageal signet ring cell carcinoma and construction of a nomogram prediction model [J]. JOURNAL OF CLINICAL SURGERY, 2024, 32(7): 712-715.
[2] SUN Yang, WANG Hao, MA Teng, LIU Yongji, MIAO Dan, SHI Ling. Analysis of therapeutic effect and prognostic factors of intravenous thrombolysis combined with mechanical thrombectomy with Trevo stent in the treatment of ischemic stroke [J]. JOURNAL OF CLINICAL SURGERY, 2024, 32(5): 468-471.
[3] QIN Fei, LI Fan. The expression of miR-542-3p and long chain non-coding RNA taurine up-regulated gene 1 in serum of patients with severe traumatic brain injury and their relationship with prognosis [J]. JOURNAL OF CLINICAL SURGERY, 2024, 32(5): 472-475.
[4] LI Meng, NI Qianyang, YU Suyang, ZHANG Yan, LI Hongyan. Significance and prognostic value of integrin α5,β1 and β2 in colorectal cancer [J]. JOURNAL OF CLINICAL SURGERY, 2024, 32(5): 502-505.
[5] HUANG Hongwei,CHEN Qi,LIAO Wei,ZHANG Kaiyue,WANG Hao,MEI Bin. Postoperative adjuvant immunotherapy for huge hepatocellular carcinoma in China liver cancer staging Ⅲa [J]. JOURNAL OF CLINICAL SURGERY, 2024, 32(4): 386-390.
[6] TANG Jiayan*,MAO Tiantian,ZHANG Min,ZHONG Ying. The value of serum miR-325-3p and fibroblast growth factor 10 expression levels in evaluating the condition and prognosis of patients with acute pancreatitis [J]. JOURNAL OF CLINICAL SURGERY, 2024, 32(4): 401-405.
[7] LIN Yong,ZHAO Zhanxue. Expression of forkhead box protein M1 and programmed cell death receptor 1 ligand in gastric cancer and their correlation with clinical prognosis [J]. JOURNAL OF CLINICAL SURGERY, 2024, 32(4): 417-420.
[8] SHEN Hui,YUN Tianqi,DAI Weihong. Construction and validation of a risk prediction model for the poor prognosis after repair of traumatic perforation of gastrointestinal tract following emergency admission for acute and critical multiple injuries [J]. JOURNAL OF CLINICAL SURGERY, 2024, 32(4): 425-428.
[9] LIAO Hanqi,TANG Yi,HU Kai,JIANG Geng. The expression of forkhead box C1 and SRY-related HMG-box 11 in cardiac cancer tissue and their relationship with clinical pathological characteristics and prognosis of patients [J]. JOURNAL OF CLINICAL SURGERY, 2024, 32(3): 293-297.
[10] ZHAO Tianhao, ZHAO Chun. Survival prognosis of multiple malignant tumors with secondary primary esophageal cancer:a population-based analysis [J]. JOURNAL OF CLINICAL SURGERY, 2024, 32(2): 158-163.
[11] YAN Xiaokun, WU Qinghua, CHEN Shaomu, CHENG Zewen. Predictive value of postoperative drainage volume and lung function for pulmonary complications after thoracoscopic lobectomy in patients with non-small cell lung cancer [J]. JOURNAL OF CLINICAL SURGERY, 2023, 31(9): 848-851.
[12] WANG Qingfeng, LU Jingjing, LU Shenglin, WANG Yuan, WU Yongfeng, ZHANG Mingfu. Analysis of related influencing factors and prognosis of complications of laparoscopic radical gastrectomy after neoadjuvant chemotherapy [J]. JOURNAL OF CLINICAL SURGERY, 2023, 31(9): 860-863.
[13] Ailijiang· Duolikun, Aizizi· Abulaiti, CHEN Kang. Expression levels and clinical significance of plasma lncRNA ANRIL and miR-191 in patients with non-small cell lung cancer [J]. JOURNAL OF CLINICAL SURGERY, 2023, 31(8): 729-732.
[14] SUN Fei, ZHOU Jiaquan, WANG Fei. Increased tissue POLR3G expression predicts adjuvant chemotherapy response and poor prognosis in muscular invasive bladder cancer [J]. JOURNAL OF CLINICAL SURGERY, 2023, 31(8): 763-767.
[15] LIANG Linhu, ZHANG Zhengrong, LI Haoran, CHENG Zhengwu, JIANG Houxiang. Neurotropic invasion in patients with colorectal cancer resection and its correlation with prognosis [J]. JOURNAL OF CLINICAL SURGERY, 2023, 31(8): 773-777.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 744 .
[2] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 747 .
[3] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 783 .
[4] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 796 .
[5] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 802 .
[6] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(11): 831 .
[7] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(11): 848 .
[8] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(11): 872 .
[9] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(11): 879 .
[10] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(11): 826 .